tiprankstipranks
Trending News
More News >
Arcutis Biotherapeutics (ARQT)
NASDAQ:ARQT
US Market

Arcutis Biotherapeutics (ARQT) Ownership - Who Owns Arcutis Biotherapeutics?

Compare
950 Followers

Arcutis Biotherapeutics (ARQT) Ownership Overview

9.46%16.22%0.20%13.83%60.30%
0.20% Other Institutional Investors
13.83% ETFs
60.30% Public Companies and Individual Investors
The ownership structure of Arcutis Biotherapeutics (ARQT) stock is a mix of institutional, retail, and individual investors. Approximately 30.25% of the company’s stock is owned by Institutional Investors, 9.46% is owned by Insiders, and 60.30% is owned by Public Companies and Individual Investors.
The ownership structure of Arcutis Biotherapeutics (ARQT) stock is a mix of institutional, retail, and individual investors. Approximately 16.42% of the company’s stock is owned by Institutional Investors, 9.46% is owned by Insiders, and 13.83% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Jan 02, 2026
xxxxxxxxxxxxx
$49549
Nov 25, 2025
xxxxxxxxxxxxx
$777872
Nov 21, 2025
xxxxxxxxxxxxx
$72131
Nov 21, 2025
xxxxxxxxxxxxx
$455291

Recent Hedge Fund Trading Activity

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
8,862,862Insider7.24%237,347,444
5,597,056Institution4.57%149,889,160
5,046,370Institution4.12%135,141,789
4,564,905Institution3.73%122,248,156
4,429,108Institution3.62%118,611,512
3,360,583Institution2.74%89,996,413
3,168,209Institution2.59%84,844,637
2,269,514Institution1.85%60,777,585
1,164,844Institution0.95%31,194,522
1,136,843Institution0.93%30,444,656

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
4,564,905Institution3.73%122,248,156
3,168,209Institution2.59%84,844,637
2,269,514Institution1.85%60,777,585
1,164,844Institution0.95%31,194,522
1,136,843Institution0.93%30,444,656
1,129,425Institution0.92%30,246,002
1,084,821Institution0.89%29,051,506
605,275Institution0.49%16,209,265
593,912Institution0.48%15,904,963
505,651Institution0.41%13,541,334

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
3,401,260Institution2.78%104,248,619
3,173,215Institution2.59%89,548,127
2,686,734Institution2.19%71,950,737
1,164,336Institution0.95%35,686,898
966,426Institution0.79%25,880,888
837,014Institution0.68%20,696,382
795,148Institution0.65%21,294,063
535,206Institution0.44%15,103,513
527,394Institution0.43%16,164,626
327,611Institution0.27%10,041,277

FAQ

Who Owns Arcutis Biotherapeutics (ARQT)?
According to the latest TipRanks data, approximately 0.20% of the company's stock is held by institutional investors, 9.46% is held by insiders, and 60.30% is held by retail investors.
    What percentage of Arcutis Biotherapeutics (ARQT) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.20% of Arcutis Biotherapeutics (ARQT) stock is held by institutional investors.
      What percentage of Arcutis Biotherapeutics (ARQT) stock is held by retail investors?
      According to the latest TipRanks data, approximately 60.30% of Arcutis Biotherapeutics (ARQT) stock is held by retail investors.
        Who owns the most shares of Arcutis Biotherapeutics (ARQT)?
        Patrick Heron owns the most shares of Arcutis Biotherapeutics (ARQT).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.